Neurocrine Biosciences
NBIX
#1302
Rank
ยฃ13.20 B
Marketcap
ยฃ130.51
Share price
2.40%
Change (1 day)
14.60%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): ยฃ1.59

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is ยฃ5.25. In 2022 the company made an earnings per share (EPS) of ยฃ1.21 an increase over its 2021 EPS that were of ยฃ0.72.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.5930.94%
2022ยฃ1.2169.47%
2021ยฃ0.72-78.21%
2020ยฃ3.29990%
2019ยฃ0.3081.82%
2018ยฃ0.17-113.5%
2017-ยฃ1.230.62%
2016-ยฃ1.2257.28%
2015-ยฃ0.7825.61%
2014-ยฃ0.6218.84%
2013-ยฃ0.52-1085.71%
2012ยฃ0.05274-89.71%
2011ยฃ0.51-500%
2010-ยฃ0.13-86.92%
2009-ยฃ0.98-43.48%
2008-ยฃ1.73-57.8%
2007-ยฃ4.1192.58%
2006-ยฃ2.13371.67%
2005-ยฃ0.45-52.76%
2004-ยฃ0.9636.56%
2003-ยฃ0.70-70%
2002-ยฃ2.34118.31%
2001-ยฃ1.078.4%
2000-ยฃ0.9948.86%
1999-ยฃ0.66-20%
1998-ยฃ0.83-479.31%
1997ยฃ0.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.53-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ4.41-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.28 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-ยฃ0.15-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.53-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ3.90-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ5.69-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.15-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK